Your browser doesn't support javascript.
loading
FGF-21 Conducts a Liver-Brain-Kidney Axis to Promote Renal Cell Carcinoma.
Li, Zongyu; Zhang, Xinyi; Zhu, Wanling; Zhang, Cuiling; Sadak, Katherine; Halberstam, Alexandra A; Brown, Jason R; Perry, Curtis J; Bunn, Azia; Braun, David A; Adeniran, Adebowale; Lee, Sangwon; Wang, Andrew; Perry, Rachel J.
Afiliação
  • Li Z; Department of Internal Medicine, Yale University School of Medicine.
  • Zhang X; Department of Cellular & Molecular Physiology, Yale University School of Medicine.
  • Zhu W; Department of Internal Medicine, Yale University School of Medicine.
  • Zhang C; Department of Cellular & Molecular Physiology, Yale University School of Medicine.
  • Sadak K; Department of Internal Medicine, Yale University School of Medicine.
  • Halberstam AA; Department of Cellular & Molecular Physiology, Yale University School of Medicine.
  • Brown JR; Department of Internal Medicine, Yale University School of Medicine.
  • Perry CJ; Department of Immunobiology, Yale University School of Medicine.
  • Bunn A; Department of Internal Medicine, Yale University School of Medicine.
  • Braun DA; Department of Internal Medicine, Yale University School of Medicine.
  • Adeniran A; Department of Cellular & Molecular Physiology, Yale University School of Medicine.
  • Lee S; Department of Internal Medicine, Division of Medical Oncology, University Hospitals Seidman Cancer Center.
  • Wang A; Case Western Reserve University.
  • Perry RJ; Department of Internal Medicine, Yale University School of Medicine.
bioRxiv ; 2023 Apr 13.
Article em En | MEDLINE | ID: mdl-37090652

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article